Effectiveness of Antiplatelet Drugs Under Therapeutic Hypothermia: A Comprehensive Review

Out‐of‐hospital cardiac arrest is among the most frequent causes of death worldwide. Immediate intervention, as well as dual antiplatelet therapy consisting of acetylsalicylic acid and a P2Y12 inhibitor is often recommended. In line with the growing number of reports on cardiac arrest treatment, the...

Full description

Saved in:
Bibliographic Details
Published in:Clinical pharmacology and therapeutics 2019-11, Vol.106 (5), p.993-1005
Main Authors: Eyileten, Ceren, Soplinska, Aleksandra, Pordzik, Justyna, Siller‐Matula, Jolanta M., Postuła, Marek
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3212-993f3469412f0e5fa7641a0dddc0bcfe938f918d229d55fa1cf815e07210347b3
cites cdi_FETCH-LOGICAL-c3212-993f3469412f0e5fa7641a0dddc0bcfe938f918d229d55fa1cf815e07210347b3
container_end_page 1005
container_issue 5
container_start_page 993
container_title Clinical pharmacology and therapeutics
container_volume 106
creator Eyileten, Ceren
Soplinska, Aleksandra
Pordzik, Justyna
Siller‐Matula, Jolanta M.
Postuła, Marek
description Out‐of‐hospital cardiac arrest is among the most frequent causes of death worldwide. Immediate intervention, as well as dual antiplatelet therapy consisting of acetylsalicylic acid and a P2Y12 inhibitor is often recommended. In line with the growing number of reports on cardiac arrest treatment, therapeutic hypothermia (TH) has been proposed for unconscious patients to improve neurological outcomes. Nevertheless, studies report controversial and often discrepant results on the effect of hypothermia on blood coagulability and platelet reactivity. In this review, we summarize the knowledge on platelet function under diverse hypothermic conditions. Additionally, we review the current literature on the effect of systemic hypothermia on pharmacokinetic and pharmacodynamic properties of antiplatelet agents. It has been shown that TH can alter the effectiveness of antiplatelet agents, including P2Y12 inhibitors, through multiple mechanisms, hence, special attention should be paid while implementing antiplatelet therapy in patients under TH conditions.
doi_str_mv 10.1002/cpt.1492
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2232113499</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2232113499</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3212-993f3469412f0e5fa7641a0dddc0bcfe938f918d229d55fa1cf815e07210347b3</originalsourceid><addsrcrecordid>eNp1kEtLAzEUhYMotlbBXyBZupmax2Q6cVdqtYKgSLtwFaaZGzsyL5NMS_-9qa3duboc7sd34CB0TcmQEsLudOuHNJbsBPWp4CxKBBenqE8IkZFkPOmhC-e-Qoxlmp6jHqdEiJSnffQxNQa0L9ZQg3O4MXhc-6ItMw8lePxgu0-HF3UOFs9XYLMWOl9oPNu2jQ-5KrJ7PMaTpmotrKB2QYTfYV3A5hKdmax0cHW4A7R4nM4ns-jl9el5Mn6JNGeURVJyw-NExpQZAsJkoySmGcnzXJOlNiB5aiRNc8ZkLsKbapNSAWTEKOHxaMkH6HbvbW3z3YHzqiqchrLMamg6pxgLPZTHoeiIats4Z8Go1hZVZreKErUbUoUh1W7IgN4crN2ygvwI_i0XgGgPbIoStv-K1ORt_iv8Ad_5fHs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2232113499</pqid></control><display><type>article</type><title>Effectiveness of Antiplatelet Drugs Under Therapeutic Hypothermia: A Comprehensive Review</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Eyileten, Ceren ; Soplinska, Aleksandra ; Pordzik, Justyna ; Siller‐Matula, Jolanta M. ; Postuła, Marek</creator><creatorcontrib>Eyileten, Ceren ; Soplinska, Aleksandra ; Pordzik, Justyna ; Siller‐Matula, Jolanta M. ; Postuła, Marek</creatorcontrib><description>Out‐of‐hospital cardiac arrest is among the most frequent causes of death worldwide. Immediate intervention, as well as dual antiplatelet therapy consisting of acetylsalicylic acid and a P2Y12 inhibitor is often recommended. In line with the growing number of reports on cardiac arrest treatment, therapeutic hypothermia (TH) has been proposed for unconscious patients to improve neurological outcomes. Nevertheless, studies report controversial and often discrepant results on the effect of hypothermia on blood coagulability and platelet reactivity. In this review, we summarize the knowledge on platelet function under diverse hypothermic conditions. Additionally, we review the current literature on the effect of systemic hypothermia on pharmacokinetic and pharmacodynamic properties of antiplatelet agents. It has been shown that TH can alter the effectiveness of antiplatelet agents, including P2Y12 inhibitors, through multiple mechanisms, hence, special attention should be paid while implementing antiplatelet therapy in patients under TH conditions.</description><identifier>ISSN: 0009-9236</identifier><identifier>EISSN: 1532-6535</identifier><identifier>DOI: 10.1002/cpt.1492</identifier><identifier>PMID: 31055838</identifier><language>eng</language><publisher>United States</publisher><ispartof>Clinical pharmacology and therapeutics, 2019-11, Vol.106 (5), p.993-1005</ispartof><rights>2019 The Authors © 2019 American Society for Clinical Pharmacology and Therapeutics</rights><rights>2019 The Authors Clinical Pharmacology &amp; Therapeutics © 2019 American Society for Clinical Pharmacology and Therapeutics.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3212-993f3469412f0e5fa7641a0dddc0bcfe938f918d229d55fa1cf815e07210347b3</citedby><cites>FETCH-LOGICAL-c3212-993f3469412f0e5fa7641a0dddc0bcfe938f918d229d55fa1cf815e07210347b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31055838$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Eyileten, Ceren</creatorcontrib><creatorcontrib>Soplinska, Aleksandra</creatorcontrib><creatorcontrib>Pordzik, Justyna</creatorcontrib><creatorcontrib>Siller‐Matula, Jolanta M.</creatorcontrib><creatorcontrib>Postuła, Marek</creatorcontrib><title>Effectiveness of Antiplatelet Drugs Under Therapeutic Hypothermia: A Comprehensive Review</title><title>Clinical pharmacology and therapeutics</title><addtitle>Clin Pharmacol Ther</addtitle><description>Out‐of‐hospital cardiac arrest is among the most frequent causes of death worldwide. Immediate intervention, as well as dual antiplatelet therapy consisting of acetylsalicylic acid and a P2Y12 inhibitor is often recommended. In line with the growing number of reports on cardiac arrest treatment, therapeutic hypothermia (TH) has been proposed for unconscious patients to improve neurological outcomes. Nevertheless, studies report controversial and often discrepant results on the effect of hypothermia on blood coagulability and platelet reactivity. In this review, we summarize the knowledge on platelet function under diverse hypothermic conditions. Additionally, we review the current literature on the effect of systemic hypothermia on pharmacokinetic and pharmacodynamic properties of antiplatelet agents. It has been shown that TH can alter the effectiveness of antiplatelet agents, including P2Y12 inhibitors, through multiple mechanisms, hence, special attention should be paid while implementing antiplatelet therapy in patients under TH conditions.</description><issn>0009-9236</issn><issn>1532-6535</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp1kEtLAzEUhYMotlbBXyBZupmax2Q6cVdqtYKgSLtwFaaZGzsyL5NMS_-9qa3duboc7sd34CB0TcmQEsLudOuHNJbsBPWp4CxKBBenqE8IkZFkPOmhC-e-Qoxlmp6jHqdEiJSnffQxNQa0L9ZQg3O4MXhc-6ItMw8lePxgu0-HF3UOFs9XYLMWOl9oPNu2jQ-5KrJ7PMaTpmotrKB2QYTfYV3A5hKdmax0cHW4A7R4nM4ns-jl9el5Mn6JNGeURVJyw-NExpQZAsJkoySmGcnzXJOlNiB5aiRNc8ZkLsKbapNSAWTEKOHxaMkH6HbvbW3z3YHzqiqchrLMamg6pxgLPZTHoeiIats4Z8Go1hZVZreKErUbUoUh1W7IgN4crN2ygvwI_i0XgGgPbIoStv-K1ORt_iv8Ad_5fHs</recordid><startdate>201911</startdate><enddate>201911</enddate><creator>Eyileten, Ceren</creator><creator>Soplinska, Aleksandra</creator><creator>Pordzik, Justyna</creator><creator>Siller‐Matula, Jolanta M.</creator><creator>Postuła, Marek</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201911</creationdate><title>Effectiveness of Antiplatelet Drugs Under Therapeutic Hypothermia: A Comprehensive Review</title><author>Eyileten, Ceren ; Soplinska, Aleksandra ; Pordzik, Justyna ; Siller‐Matula, Jolanta M. ; Postuła, Marek</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3212-993f3469412f0e5fa7641a0dddc0bcfe938f918d229d55fa1cf815e07210347b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Eyileten, Ceren</creatorcontrib><creatorcontrib>Soplinska, Aleksandra</creatorcontrib><creatorcontrib>Pordzik, Justyna</creatorcontrib><creatorcontrib>Siller‐Matula, Jolanta M.</creatorcontrib><creatorcontrib>Postuła, Marek</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical pharmacology and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Eyileten, Ceren</au><au>Soplinska, Aleksandra</au><au>Pordzik, Justyna</au><au>Siller‐Matula, Jolanta M.</au><au>Postuła, Marek</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effectiveness of Antiplatelet Drugs Under Therapeutic Hypothermia: A Comprehensive Review</atitle><jtitle>Clinical pharmacology and therapeutics</jtitle><addtitle>Clin Pharmacol Ther</addtitle><date>2019-11</date><risdate>2019</risdate><volume>106</volume><issue>5</issue><spage>993</spage><epage>1005</epage><pages>993-1005</pages><issn>0009-9236</issn><eissn>1532-6535</eissn><abstract>Out‐of‐hospital cardiac arrest is among the most frequent causes of death worldwide. Immediate intervention, as well as dual antiplatelet therapy consisting of acetylsalicylic acid and a P2Y12 inhibitor is often recommended. In line with the growing number of reports on cardiac arrest treatment, therapeutic hypothermia (TH) has been proposed for unconscious patients to improve neurological outcomes. Nevertheless, studies report controversial and often discrepant results on the effect of hypothermia on blood coagulability and platelet reactivity. In this review, we summarize the knowledge on platelet function under diverse hypothermic conditions. Additionally, we review the current literature on the effect of systemic hypothermia on pharmacokinetic and pharmacodynamic properties of antiplatelet agents. It has been shown that TH can alter the effectiveness of antiplatelet agents, including P2Y12 inhibitors, through multiple mechanisms, hence, special attention should be paid while implementing antiplatelet therapy in patients under TH conditions.</abstract><cop>United States</cop><pmid>31055838</pmid><doi>10.1002/cpt.1492</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0009-9236
ispartof Clinical pharmacology and therapeutics, 2019-11, Vol.106 (5), p.993-1005
issn 0009-9236
1532-6535
language eng
recordid cdi_proquest_miscellaneous_2232113499
source Wiley-Blackwell Read & Publish Collection
title Effectiveness of Antiplatelet Drugs Under Therapeutic Hypothermia: A Comprehensive Review
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T09%3A15%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effectiveness%20of%20Antiplatelet%20Drugs%20Under%20Therapeutic%20Hypothermia:%20A%20Comprehensive%20Review&rft.jtitle=Clinical%20pharmacology%20and%20therapeutics&rft.au=Eyileten,%20Ceren&rft.date=2019-11&rft.volume=106&rft.issue=5&rft.spage=993&rft.epage=1005&rft.pages=993-1005&rft.issn=0009-9236&rft.eissn=1532-6535&rft_id=info:doi/10.1002/cpt.1492&rft_dat=%3Cproquest_cross%3E2232113499%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3212-993f3469412f0e5fa7641a0dddc0bcfe938f918d229d55fa1cf815e07210347b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2232113499&rft_id=info:pmid/31055838&rfr_iscdi=true